Microsize specializes in Particle Size Reduction, Powder Classification, and Analytical Services, catering to a diverse clientele, including small biotechs, Big Pharma, CDMOs (API, Dosage Form, Integrated), and Functional Excipient Companies. Our expertise in milling and micronization processes enables us to develop and manufacture products with unique physical property challenges.
We offer high-turn feasibility studies within our development suites, requiring as little as 1-5 grams of API. For highly potent compounds, including cytotoxics (HPAPIs), we provide world-class high containment infrastructure in our R&D labs and GMP suites to match your development stage.
Our solutions cover Small Molecule APIs and HPAPIs, Functional Excipients, NCEs, 505b2s, and Generics. We support every phase of development, from Discovery and Phases I-III to Commercial Launch and Generic production.
As North America's largest independent pharmaceutical micronization business, Microsize is a pioneer in enhancing dissolution and bioavailability of Active Pharmaceutical Ingredients (APIs). We rapidly develop, scale-up, and process APIs and excipients from grams to multi-metric tons, including highly potent compounds. Choose Microsize as your trusted partner, known for speed, responsiveness, and a high customer-touch business model. Think BIG...Think Microsize.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
11-50 employees
-
Headquarters
-
Quakertown, Pennsylvania
-
Type
-
Privately Held
-
Founded
-
1994
-
Specialties
-
micronization, particle size reduction, bioavailability, solubility, active pharmaceutical ingredients, GMP, CDMO, CMO, jet milling, particle engineering, API, HPAPI, Excipients, high potency, drug substance, drug product, milling, sieving, cryomilling, and co-micronization
